Retrospective analysis of the international standard-dose FOLFIRI (plus bevacizumab) regimen in Japanese patients with unresectable advanced or recurrent colorectal carcinoma

Tomohiro Nishi, Yasuo Hamamoto, Etsuko Warita, Junko Miyamoto, Noriyuki Akutsu, Yasuhiro Yamanaka, Michitaka Nagase, Hirofumi Fujii

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Retrospective analysis of the international standard-dose FOLFIRI (plus bevacizumab) regimen in Japanese patients with unresectable advanced or recurrent colorectal carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences